ASCO Study Abstract Shows Cizzle Bio’s CIZ1B Biomarker Test for Lung Cancer Could Save $518M in Annual Medicare Costs, issued 22-May-2025 by Cizzle Bio over PR Newswire, we are
First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy, for Patients With Progression On or After Platinum-Based Chemotherapy Amgen announced that the global
All secondary endpoints required to support eyonis LCS’ intended use and desired marketing claims achieved in RELIVE Median Technologies manufacturer of eyonis, a suite of artificial
Mediaplanet, announces the launch of Lung Health. Chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and other lung conditions affect millions worldwide, yet many remain unaware
Fuel up with free Health Tech Insights
